How to Order Engineered Cells, Multi-Guide GKO Kits, and Screening Libraries

In March of 2024, Synthego sold a portion of it's business to Telegraph Hill Partners, who formed a new company called Editco. While previously announced in the media and marketing channels, we wanted to provide some extra visibility to customers who may have been caught unaware of this change. The original press release is available here. Born from Synthego’s cell engineering expertise, EditCo is uniquely positioned to deliver edited cells and highly optimized guide RNA designs for the rapidly expanding CRISPR market. EditCo operates as an independent business from Synthego.

For customers looking to buy Gene Knockout Kits (multi-guide GKO), Engineered Cell Lines, iPS Cell Lines, & Arrayed Screening Libraries, these products are all available for sale at https://editco.bio

The ICE application, previously hosted by Synthego, has also transitioned to EditCo. This is available at https://ice.editco.bio

Synthego remains dedicated to delivering best-in-class CRISPR solutions with a mission to accelerate research and development in the pursuit of improved human health. By providing unparalleled access to CRISPR solutions at scale, we enable agility in life science discovery and clinical advancement. With streamlined licensing models and exceptional technical expertise, Synthego empowers researchers and developers to unlock better patient outcomes through innovative CRISPR cell and gene therapies.